(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COLOSAFE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

COLOSAFE

ST13

US500000079314440

Class

5, 10

Filing

79314440

Registration

6720877

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/03/2022

Trademark type

Combined

Nice classes

5, 10

Filing date

03/16/2021

Registration date

05/24/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

05/24/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

CN

Examiner

STADELI, MARTA

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "COLOSAFE" in stylized font with the letters "OLO" creating eyes and a nose with a curved line under the letters creating a smile of a stylized face, and below aligned on the right are three Chinese characters.

Holders and representatives

Holders

Creative Biosciences (Guangzhou) Co., Ltd.

Representatives

Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biological preparations for the treatment of cancer; medicines for human purposesmedicinal preparation for colorectal diseases and colorectal cancer; stem cells for medical purposes; dietetic preparations adapted for medical use; air purifying preparations; chemical preparations for pharmaceutical or medical purposesfor the treatment of cancer; stem cells for veterinary purposes; teeth filling material

Class 10

Probes for medical purposes; medical apparatus and instrumentsmedical apparatus and instruments for monitoring characteristic of bloodbody fluid and excrementmedical apparatus and instruments for treating cancersmedical apparatus and instruments for preventing or reversing cancersmedical apparatus and instruments for measuring and displaying tumour cells in the bloodbody fluid and excrement samples; testing apparatus for medical purposestesting apparatus for bloodbody fluid and excrementmedical diagnostic apparatus for testing DNA and RNA samplestumour cells testing apparatus for medical use; apparatus for use in medical analysisapparatus for analyzing bloodbody fluid and excrementmedical diagnostic apparatus for analyzing and measuring tumour cells in the bloodbody fluid and excrement samples; diagnostic apparatus for medical purposesdiagnostic apparatus for the detection and screening of tumorsmedical diagnostic apparatus for testing tumor cells and DNA; apparatus for DNA and RNA exams for medical purposes; apparatus for taking blood samples; radiological apparatus for medical purposes; physiotherapy apparatuscolorectal hydrotherapy apparatus for physical therapy purposes; furniture especially made for medical purposes

Publications

History of USPTO decisions and trademark events.

26 publications found

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/09/2022

FIMP

FINAL DISPOSITION PROCESSED

09/09/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/24/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/22/2022

PUBO

PUBLISHED FOR OPPOSITION

02/22/2022

GPNX

NOTIFICATION PROCESSED BY IB

02/20/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/02/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/02/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/15/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/14/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/14/2022

RFNT

REFUSAL PROCESSED BY IB

12/19/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/26/2021

RFRR

REFUSAL PROCESSED BY MPU

11/26/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/27/2021

CNRT

NON-FINAL ACTION WRITTEN

10/26/2021

DOCK

ASSIGNED TO EXAMINER

10/18/2021

MAFR

APPLICATION FILING RECEIPT MAILED

07/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/08/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/01/2021

Continuous trademark protection

Get notified about every new filing that threatens COLOSAFE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.